Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 123

1.

Protocol, rationale and design of PEOPLE (Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar): a cluster randomized trial on effectiveness of different modalities of implementation of post-exposure prophylaxis of leprosy contacts.

Ortuno-Gutierrez N, Younoussa A, Randrianantoandro A, Braet S, Cauchoix B, Ramboarina S, Baco A, Mzembaba A, Salim Z, Amidy M, Grillone S, Richardus JH, de Jong BC, Hasker E.

BMC Infect Dis. 2019 Dec 5;19(1):1033. doi: 10.1186/s12879-019-4649-0.

2.

Diabetes Mellitus among new tuberculosis patients in Bamako, Mali.

Diarra B, Tolofoudie M, Sarro YS, Togo ACG, Bane S, Nientao I, Cisse AB, Kone M, Somboro A, Degoga B, Diallo F, Coulibaly G, Kodio O, Sanogo M, Kone B, Diabate S, Baya B, Kone A, Dabitao D, Maiga M, Belson M, Dao S, Maiga II, Murphy RL, Siddiqui S, Toloba Y, Konate B, Doumbia S, de Jong BC, Diallo S.

J Clin Tuberc Other Mycobact Dis. 2019 Nov 1;17:100128. doi: 10.1016/j.jctube.2019.100128. eCollection 2019 Dec.

3.

Systematic screening for tuberculosis among hospital outpatients in Cameroon: The role of screening and testing algorithms to improve case detection.

Sander MS, Laah SN, Titahong CN, Lele C, Kinge T, de Jong BC, Abena JF, Codlin AJ, Creswell J.

J Clin Tuberc Other Mycobact Dis. 2019 Feb 18;15:100095. doi: 10.1016/j.jctube.2019.100095. eCollection 2019 May.

4.

World Health Organization 2018 treatment guidelines for rifampicin-resistant tuberculosis: uncertainty, potential risks and the way forward.

Van Deun A, Decroo T, Tahseen S, Trébucq A, Schwoebel V, Ortuno-Gutierrez N, de Jong BC, Rieder HL, Piubello A, Chiang CY.

Int J Antimicrob Agents. 2019 Oct 15. pii: S0924-8579(19)30277-8. doi: 10.1016/j.ijantimicag.2019.10.003. [Epub ahead of print]

PMID:
31626907
5.

In reply: A human rights-based approach to tuberculosis diagnosis.

Van Deun A, Tahseen S, Affolabi D, Hossain MA, Joloba ML, Angra PK, Ridderhof JC, de Jong BC, Rieder HL.

Int J Tuberc Lung Dis. 2019 Aug 1;23(8):959-960. doi: 10.5588/ijtld.18.0133. No abstract available.

PMID:
31533887
6.

Bridging the TB data gap: in silico extraction of rifampicin-resistant tuberculosis diagnostic test results from whole genome sequence data.

Ng KCS, Ngabonziza JCS, Lempens P, de Jong BC, van Leth F, Meehan CJ.

PeerJ. 2019 Aug 26;7:e7564. doi: 10.7717/peerj.7564. eCollection 2019.

7.

Variable ability of rapid tests to detect Mycobacterium tuberculosis rpoB mutations conferring phenotypically occult rifampicin resistance.

Torrea G, Ng KCS, Van Deun A, André E, Kaisergruber J, Ssengooba W, Desmaretz C, Gabriels S, Driesen M, Diels M, Asnong S, Fissette K, Gumusboga M, Rigouts L, Affolabi D, Joloba M, De Jong BC.

Sci Rep. 2019 Aug 14;9(1):11826. doi: 10.1038/s41598-019-48401-z.

8.

How Well Do Routine Molecular Diagnostics Detect Rifampin Heteroresistance in Mycobacterium tuberculosis?

Ng KCS, Supply P, Cobelens FGJ, Gaudin C, Gonzalez-Martin J, de Jong BC, Rigouts L.

J Clin Microbiol. 2019 Oct 23;57(11). pii: e00717-19. doi: 10.1128/JCM.00717-19. Print 2019 Nov.

9.

Fluoroquinolone heteroresistance in Mycobacterium tuberculosis: detection by genotypic and phenotypic assays in experimentally mixed populations.

Rigouts L, Miotto P, Schats M, Lempens P, Cabibbe AM, Galbiati S, Lampasona V, de Rijk P, Cirillo DM, de Jong BC.

Sci Rep. 2019 Aug 13;9(1):11760. doi: 10.1038/s41598-019-48289-9.

10.

Ethical Considerations for Movement Mapping to Identify Disease Transmission Hotspots.

de Jong BC, Gaye BM, Luyten J, van Buitenen B, André E, Meehan CJ, O'Siochain C, Tomsu K, Urbain J, Grietens KP, Njue M, Pinxten W, Gehre F, Nyan O, Buvé A, Roca A, Ravinetto R, Antonio M.

Emerg Infect Dis. 2019 Jul;25(7). doi: 10.3201/eid2507.181421.

11.

Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues.

Meehan CJ, Goig GA, Kohl TA, Verboven L, Dippenaar A, Ezewudo M, Farhat MR, Guthrie JL, Laukens K, Miotto P, Ofori-Anyinam B, Dreyer V, Supply P, Suresh A, Utpatel C, van Soolingen D, Zhou Y, Ashton PM, Brites D, Cabibbe AM, de Jong BC, de Vos M, Menardo F, Gagneux S, Gao Q, Heupink TH, Liu Q, Loiseau C, Rigouts L, Rodwell TC, Tagliani E, Walker TM, Warren RM, Zhao Y, Zignol M, Schito M, Gardy J, Cirillo DM, Niemann S, Comas I, Van Rie A.

Nat Rev Microbiol. 2019 Sep;17(9):533-545. doi: 10.1038/s41579-019-0214-5. Review.

PMID:
31209399
12.

Clustering of leprosy beyond the household level in a highly endemic setting on the Comoros, an observational study.

Ortuno-Gutierrez N, Baco A, Braet S, Younoussa A, Mzembaba A, Salim Z, Amidy M, Grillone S, de Jong BC, Richardus JH, Hasker E.

BMC Infect Dis. 2019 Jun 7;19(1):501. doi: 10.1186/s12879-019-4116-y.

13.

Storage of Sputum in Cetylpyridinium Chloride, OMNIgene.SPUTUM, and Ethanol Is Compatible with Molecular Tuberculosis Diagnostic Testing.

Sanoussi CN, de Jong BC, Affolabi D, Meehan CJ, Odoun M, Rigouts L.

J Clin Microbiol. 2019 Jun 25;57(7). pii: e00275-19. doi: 10.1128/JCM.00275-19. Print 2019 Jul.

14.

Mycobacterium ulcerans Population Genomics To Inform on the Spread of Buruli Ulcer across Central Africa.

Vandelannoote K, Phanzu DM, Kibadi K, Eddyani M, Meehan CJ, Jordaens K, Leirs H, Portaels F, Stinear TP, Harris SR, de Jong BC.

mSphere. 2019 Feb 6;4(1). pii: e00472-18. doi: 10.1128/mSphere.00472-18.

15.

Twenty years of rifampicin resistance surveillance in Bangladesh: periodic vs. continuous monitoring.

Van Deun A, Aung KJM, Hossain MA, Salim MAH, Gumusboga M, de Jong BC, Decroo T.

Int J Tuberc Lung Dis. 2018 Dec 1;22(12):1450-1461. doi: 10.5588/ijtld.18.0158.

PMID:
30606317
16.

Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a diagnostic evaluation study.

Tadesse M, Abebe G, Bekele A, Bezabih M, Yilma D, Apers L, de Jong BC, Rigouts L.

Clin Microbiol Infect. 2019 Aug;25(8):1000-1005. doi: 10.1016/j.cmi.2018.12.018. Epub 2018 Dec 22.

PMID:
30583052
17.

Sputum smear microscopy in the Xpert® MTB/RIF era.

Van Deun A, Tahseen S, Affolabi D, Hossain MA, Joloba ML, Angra PK, Ridderhof JC, de Jong BC, Rieder HL.

Int J Tuberc Lung Dis. 2019 Jan 1;23(1):12-18. doi: 10.5588/ijtld.18.0553. Epub 2018 Dec 19.

PMID:
30567624
18.

Mycobacterium africanum (Lineage 6) shows slower sputum smear conversion on tuberculosis treatment than Mycobacterium tuberculosis (Lineage 4) in Bamako, Mali.

Diarra B, Kone M, Togo ACG, Sarro YDS, Cisse AB, Somboro A, Degoga B, Tolofoudie M, Kone B, Sanogo M, Baya B, Kodio O, Maiga M, Belson M, Orsega S, Krit M, Dao S, Maiga II, Murphy RL, Rigouts L, Doumbia S, Diallo S, de Jong BC.

PLoS One. 2018 Dec 12;13(12):e0208603. doi: 10.1371/journal.pone.0208603. eCollection 2018.

19.

Multidrug-resistant tuberculosis outbreak in South Africa - Authors' reply.

Makhado NA, Nchabeleng M, Supply P, de Jong BC, André E.

Lancet Infect Dis. 2019 Feb;19(2):135-136. doi: 10.1016/S1473-3099(18)30738-2. Epub 2018 Dec 6. No abstract available.

PMID:
30528115
20.

Low sensitivity of the MPT64 identification test to detect lineage 5 of the Mycobacterium tuberculosis complex.

Sanoussi CN, de Jong BC, Odoun M, Arekpa K, Ali Ligali M, Bodi O, Harris S, Ofori-Anyinam B, Yeboah-Manu D, Otchere ID, Asante-Poku A, Anagonou S, Gagneux S, Coscolla M, Rigouts L, Affolabi D.

J Med Microbiol. 2018 Dec;67(12):1718-1727. doi: 10.1099/jmm.0.000846. Epub 2018 Nov 2.

PMID:
30388066
21.

Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study.

Makhado NA, Matabane E, Faccin M, Pinçon C, Jouet A, Boutachkourt F, Goeminne L, Gaudin C, Maphalala G, Beckert P, Niemann S, Delvenne JC, Delmée M, Razwiedani L, Nchabeleng M, Supply P, de Jong BC, André E.

Lancet Infect Dis. 2018 Dec;18(12):1350-1359. doi: 10.1016/S1473-3099(18)30496-1. Epub 2018 Oct 18.

PMID:
30342828
22.

The relationship between transmission time and clustering methods in Mycobacterium tuberculosis epidemiology.

Meehan CJ, Moris P, Kohl TA, Pečerska J, Akter S, Merker M, Utpatel C, Beckert P, Gehre F, Lempens P, Stadler T, Kaswa MK, Kühnert D, Niemann S, de Jong BC.

EBioMedicine. 2018 Nov;37:410-416. doi: 10.1016/j.ebiom.2018.10.013. Epub 2018 Oct 16.

23.

Outbreak of Tuberculosis and Multidrug-Resistant Tuberculosis, Mbuji-Mayi Central Prison, Democratic Republic of the Congo.

Kayomo MK, Hasker E, Aloni M, Nkuku L, Kazadi M, Kabengele T, Muteteke D, Kapita F, Lufulwabo A, Mukadi YD, Muyembe-Tamfum JJ, Ieven M, de Jong BC, Boelaert M.

Emerg Infect Dis. 2018 Nov;24(11):2029-2035. doi: 10.3201/eid2411.180769.

24.

Improving clinical and epidemiological predictors of Buruli ulcer.

Ayelo GA, Sopoh GE, Houezo JG, Fiodessihoue R, Affolabi D, Dossou AD, Barogui YT, Wadagni AAC, Agossadou DC, Hasker E, Portaels F, de Jong BC, Eddyani M.

PLoS Negl Trop Dis. 2018 Aug 6;12(8):e0006713. doi: 10.1371/journal.pntd.0006713. eCollection 2018 Aug.

25.

Comparative genomics of Mycobacterium africanum Lineage 5 and Lineage 6 from Ghana suggests distinct ecological niches.

Otchere ID, Coscollá M, Sánchez-Busó L, Asante-Poku A, Brites D, Loiseau C, Meehan C, Osei-Wusu S, Forson A, Laryea C, Yahayah AI, Baddoo A, Ansa GA, Aboagye SY, Asare P, Borrell S, Gehre F, Beckert P, Kohl TA, N'dira S, Beisel C, Antonio M, Niemann S, de Jong BC, Parkhill J, Harris SR, Gagneux S, Yeboah-Manu D.

Sci Rep. 2018 Jul 26;8(1):11269. doi: 10.1038/s41598-018-29620-2.

26.

Xpert Ultra Can Unambiguously Identify Specific Rifampin Resistance-Conferring Mutations.

Ng KCS, van Deun A, Meehan CJ, Torrea G, Driesen M, Gabriëls S, Rigouts L, André E, de Jong BC.

J Clin Microbiol. 2018 Aug 27;56(9). pii: e00686-18. doi: 10.1128/JCM.00686-18. Print 2018 Sep. No abstract available.

27.

Performance of OMNIgene•SPUTUM (DNA Genotek) and cetylpyridinium chloride for sputum storage prior to mycobacterial culture.

Affolabi D, Sanoussi N, Sossou A, Nys T, Bodi O, Esse M, Houeto S, Massou F, de Jong BC, Rigouts L.

J Med Microbiol. 2018 May 2. doi: 10.1099/jmm.0.000745. [Epub ahead of print]

PMID:
29717969
28.

Subcutaneous Granulomatous Inflammation due to Basidiobolomycosis: Case Reports of 3 Patients in Buruli Ulcer Endemic Areas in Benin.

Brun LVC, Roux JJ, Sopoh GE, Aguiar J, Eddyani M, Meyers WM, Stubbe D, Akele Akpo MT, Portaels F, de Jong BC.

Case Rep Pathol. 2018 Jan 10;2018:1351694. doi: 10.1155/2018/1351694. eCollection 2018.

29.

Diagnostic Accuracy of Clinical and Microbiological Signs in Patients With Skin Lesions Resembling Buruli Ulcer in an Endemic Region.

Eddyani M, Sopoh GE, Ayelo G, Brun LVC, Roux JJ, Barogui Y, Affolabi D, Faber WR, Boelaert M, Van Rie A, Portaels F, de Jong BC.

Clin Infect Dis. 2018 Aug 31;67(6):827-834. doi: 10.1093/cid/ciy197.

30.

Potential Application of Digitally Linked Tuberculosis Diagnostics for Real-Time Surveillance of Drug-Resistant Tuberculosis Transmission: Validation and Analysis of Test Results.

Ng KC, Meehan CJ, Torrea G, Goeminne L, Diels M, Rigouts L, de Jong BC, André E.

JMIR Med Inform. 2018 Feb 27;6(1):e12. doi: 10.2196/medinform.9309.

31.

Principles for constructing a tuberculosis treatment regimen: the role and definition of core and companion drugs.

Van Deun A, Decroo T, Piubello A, de Jong BC, Lynen L, Rieder HL.

Int J Tuberc Lung Dis. 2018 Mar 1;22(3):239-245. doi: 10.5588/ijtld.17.0660. Review.

PMID:
29471899
32.

Isoniazid resistance levels of Mycobacterium tuberculosis can largely be predicted by high-confidence resistance-conferring mutations.

Lempens P, Meehan CJ, Vandelannoote K, Fissette K, de Rijk P, Van Deun A, Rigouts L, de Jong BC.

Sci Rep. 2018 Feb 19;8(1):3246. doi: 10.1038/s41598-018-21378-x.

33.

Comparative Genomics Shows That Mycobacterium ulcerans Migration and Expansion Preceded the Rise of Buruli Ulcer in Southeastern Australia.

Buultjens AH, Vandelannoote K, Meehan CJ, Eddyani M, de Jong BC, Fyfe JAM, Globan M, Tobias NJ, Porter JL, Tomita T, Tay EL, Seemann T, Howden BP, Johnson PDR, Stinear TP.

Appl Environ Microbiol. 2018 Apr 2;84(8). pii: e02612-17. doi: 10.1128/AEM.02612-17. Print 2018 Apr 15.

34.

Examining human paragonimiasis as a differential diagnosis to tuberculosis in The Gambia.

Morter R, Adetifa I, Antonio M, Touray F, de Jong BC, Gower CM, Gehre F.

BMC Res Notes. 2018 Jan 15;11(1):31. doi: 10.1186/s13104-018-3134-y.

35.

The Repetitive Element RLEP Is a Highly Specific Target for Detection of Mycobacterium leprae.

Braet S, Vandelannoote K, Meehan CJ, Brum Fontes AN, Hasker E, Rosa PS, Lucena-Silva N, Rigouts L, Suffys PN, De Jong BC.

J Clin Microbiol. 2018 Feb 22;56(3). pii: e01924-17. doi: 10.1128/JCM.01924-17. Print 2018 Mar. No abstract available.

36.

The Biology and Epidemiology of Mycobacterium africanum.

Yeboah-Manu D, de Jong BC, Gehre F.

Adv Exp Med Biol. 2017;1019:117-133. doi: 10.1007/978-3-319-64371-7_6. Review.

PMID:
29116632
37.

Extensively drug resistant tuberculosis in Mali: a case report.

Diarra B, Toloba Y, Konate B, Sanogo M, Togo ACG, Camara F, Berthe G, Soumaré D, Baya B, Goita D, Sarro YDS, Maiga M, Belson M, Orsega S, Dao S, Murphy RL, Siddiqui S, de Jong BC, Doumbia S, Diallo S.

BMC Res Notes. 2017 Nov 6;10(1):561. doi: 10.1186/s13104-017-2890-4.

38.

Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide.

Ngabonziza JCS, Diallo AB, Tagliani E, Diarra B, Kadanga AE, Togo ACG, Thiam A, de Rijk WB, Alagna R, Houeto S, Ba F, Dagnra AY, Ivan E, Affolabi D, Schwoebel V, Trebucq A, de Jong BC, Rigouts L, Daneau G; “Union short MDR-TB regimen study group”.

PLoS One. 2017 Oct 31;12(10):e0187211. doi: 10.1371/journal.pone.0187211. eCollection 2017.

39.

The predominance of Ethiopian specific Mycobacterium tuberculosis families and minimal contribution of Mycobacterium bovis in tuberculous lymphadenitis patients in Southwest Ethiopia.

Tadesse M, Abebe G, Bekele A, Bezabih M, de Rijk P, Meehan CJ, de Jong BC, Rigouts L.

Infect Genet Evol. 2017 Nov;55:251-259. doi: 10.1016/j.meegid.2017.09.016. Epub 2017 Sep 15.

PMID:
28919549
40.

Emergence and clonal transmission of multi-drug-resistant tuberculosis among patients in Chad.

Ba Diallo A, Ossoga GW, Daneau G, Lo S, Ngandolo R, Djaibé CD, Djouater B, Mboup S, de Jong BC, Diallo AG, Gehre F.

BMC Infect Dis. 2017 Aug 22;17(1):579. doi: 10.1186/s12879-017-2671-7.

41.

Bacterial diversity in Buruli ulcer skin lesions: Challenges in the clinical microbiome analysis of a skin disease.

Van Leuvenhaege C, Vandelannoote K, Affolabi D, Portaels F, Sopoh G, de Jong BC, Eddyani M, Meehan CJ.

PLoS One. 2017 Jul 27;12(7):e0181994. doi: 10.1371/journal.pone.0181994. eCollection 2017.

42.

Evaluation of a novel line probe assay to detect resistance to pyrazinamide, a key drug used for tuberculosis treatment.

Driesen M, Kondo Y, de Jong BC, Torrea G, Asnong S, Desmaretz C, Mostofa KSM, Tahseen S, Whitfield MG, Cirillo DM, Miotto P, Cabibbe AM, Rigouts L.

Clin Microbiol Infect. 2018 Jan;24(1):60-64. doi: 10.1016/j.cmi.2017.05.026. Epub 2017 Jun 3.

43.

Significant under expression of the DosR regulon in M. tuberculosis complex lineage 6 in sputum.

Ofori-Anyinam B, Dolganov G, Van T, Davis JL, Walter ND, Garcia BJ, Voskuil M, Fissette K, Diels M, Driesen M, Meehan CJ, Yeboah-Manu D, Coscolla M, Gagneux S, Antonio M, Schoolnik G, Gehre F, de Jong BC.

Tuberculosis (Edinb). 2017 May;104:58-64. doi: 10.1016/j.tube.2017.03.001. Epub 2017 Mar 4.

44.

Tuberculosis resistance-conferring mutations with fitness cost among HIV-positive individuals in Uganda.

Ssengooba W, Lukoye D, Meehan CJ, Kateete DP, Joloba ML, de Jong BC, Cobelens FG, van Leth F.

Int J Tuberc Lung Dis. 2017 May 1;21(5):531-536. doi: 10.5588/ijtld.16.0544.

PMID:
28399968
45.

Some Synonymous and Nonsynonymous gyrA Mutations in Mycobacterium tuberculosis Lead to Systematic False-Positive Fluoroquinolone Resistance Results with the Hain GenoType MTBDRsl Assays.

Ajileye A, Alvarez N, Merker M, Walker TM, Akter S, Brown K, Moradigaravand D, Schön T, Andres S, Schleusener V, Omar SV, Coll F, Huang H, Diel R, Ismail N, Parkhill J, de Jong BC, Peto TE, Crook DW, Niemann S, Robledo J, Smith EG, Peacock SJ, Köser CU.

Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e02169-16. doi: 10.1128/AAC.02169-16. Print 2017 Apr.

46.

Multiple Introductions and Recent Spread of the Emerging Human Pathogen Mycobacterium ulcerans across Africa.

Vandelannoote K, Meehan CJ, Eddyani M, Affolabi D, Phanzu DM, Eyangoh S, Jordaens K, Portaels F, Mangas K, Seemann T, Marsollier L, Marion E, Chauty A, Landier J, Fontanet A, Leirs H, Stinear TP, de Jong BC.

Genome Biol Evol. 2017 Mar 1;9(3):414-426. doi: 10.1093/gbe/evx003.

47.

The majority of patients with multidrug-resistant tuberculosis in Sub-Saharan Africa present a concomitant resistance to pyrazinamide.

Daneau G, Gumusboga M, De Rijk P, Trebucq A, Rigouts L, Van Deun A, de Jong BC.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S46-S47. doi: 10.1016/j.ijmyco.2016.10.015. Epub 2016 Oct 27.

48.

Tuberculosis drug resistance in Bamako, Mali, from 2006 to 2014.

Diarra B, Goita D, Tounkara S, Sanogo M, Baya B, Togo AC, Maiga M, Sarro YS, Kone A, Kone B, M'Baye O, Coulibaly N, Kassambara H, Cisse A, Belson M, Polis MA, Otu J, Gehre F, Antonio M, Dao S, Siddiqui S, Murphy RL, de Jong BC, Diallo S.

BMC Infect Dis. 2016 Nov 28;16(1):714.

49.

The emerging threat of pre-extensively drug-resistant tuberculosis in West Africa: preparing for large-scale tuberculosis research and drug resistance surveillance.

Gehre F, Otu J, Kendall L, Forson A, Kwara A, Kudzawu S, Kehinde AO, Adebiyi O, Salako K, Baldeh I, Jallow A, Jallow M, Dagnra A, Dissé K, Kadanga EA, Idigbe EO, Onubogu C, Onyejepu N, Gaye-Diallo A, Ba-Diallo A, Rabna P, Mane M, Sanogo M, Diarra B, Dezemon Z, Sanou A, Senghore M, Kwambana-Adams BA, Demba E, Faal-Jawara T, Kumar S, Tientcheu LD, Jallow A, Ceesay S, Adetifa I, Jaye A, Pallen MJ, D'Alessandro U, Kampmann B, Adegbola RA, Mboup S, Corrah T, de Jong BC, Antonio M.

BMC Med. 2016 Nov 3;14(1):160.

50.

Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages.

Stucki D, Brites D, Jeljeli L, Coscolla M, Liu Q, Trauner A, Fenner L, Rutaihwa L, Borrell S, Luo T, Gao Q, Kato-Maeda M, Ballif M, Egger M, Macedo R, Mardassi H, Moreno M, Tudo Vilanova G, Fyfe J, Globan M, Thomas J, Jamieson F, Guthrie JL, Asante-Poku A, Yeboah-Manu D, Wampande E, Ssengooba W, Joloba M, Henry Boom W, Basu I, Bower J, Saraiva M, Vaconcellos SEG, Suffys P, Koch A, Wilkinson R, Gail-Bekker L, Malla B, Ley SD, Beck HP, de Jong BC, Toit K, Sanchez-Padilla E, Bonnet M, Gil-Brusola A, Frank M, Penlap Beng VN, Eisenach K, Alani I, Wangui Ndung'u P, Revathi G, Gehre F, Akter S, Ntoumi F, Stewart-Isherwood L, Ntinginya NE, Rachow A, Hoelscher M, Cirillo DM, Skenders G, Hoffner S, Bakonyte D, Stakenas P, Diel R, Crudu V, Moldovan O, Al-Hajoj S, Otero L, Barletta F, Jane Carter E, Diero L, Supply P, Comas I, Niemann S, Gagneux S.

Nat Genet. 2016 Dec;48(12):1535-1543. doi: 10.1038/ng.3704. Epub 2016 Oct 31.

Supplemental Content

Loading ...
Support Center